Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

NCT05673590 2023-11-08

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

612 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06110663 2023-11-01

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

Phase 3 Unknown

314 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05445791 2023-06-27

METLUNG

Phase 3 Unknown

312 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

Phase 3 Unknown

228 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

60 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01405586 2023-03-24

MILES-3

Phase 3 Unknown

299 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01656551 2023-03-24

MILES-4

Phase 3 Unknown

232 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05111197 2023-02-21

TRAILOCLORI01

Phase 3 Unknown

112 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT03849768 2023-01-20

A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients

Phase 3 Unknown

429 enrolled 18 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03924050 2022-12-27

Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI

Phase 3 Unknown

440 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05042375 2022-11-17

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Phase 3 Unknown

450 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04325763 2022-03-31

A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Phase 3 Unknown

315 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01951469 2022-03-08

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

Phase 3 Unknown

160 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05204628 2022-01-24

A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib

Phase 3 Unknown

238 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

Phase 3 Unknown

203 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02448797 2021-07-20

EVIDENCE

Phase 3 Unknown

320 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04951648 2021-07-07

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

Phase 3 Unknown

220 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04840290 2021-04-21

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase 3 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04536675 2021-04-02

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

Phase 3 Unknown

204 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Phase 3 Unknown

454 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

206 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04768075 2021-02-24

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Phase 3 Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00410683 2020-11-20

LUNG ART

Phase 3 Unknown

500 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04500704 2020-08-05

ACROSS1

Phase 3 Unknown

166 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04500717 2020-08-05

ACROSS2

Phase 3 Unknown

460 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

Phase 3 Unknown

420 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01405079 2020-02-18

ADJUVANT

Phase 3 Unknown

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03827577 2020-01-18

OMEGA

Phase 3 Unknown

195 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04028778 2019-11-08

FL-ALTER

Phase 3 Unknown

310 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04058704 2019-08-15

SMART

Phase 3 Unknown

296 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03372694 2019-06-12

Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients

Phase 3 Unknown

354 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03884192 2019-03-21

CONSIST

Phase 3 Unknown

162 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03700333 2018-10-09

Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC

Phase 3 Unknown

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03533127 2018-07-10

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Phase 3 Unknown

648 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03432637 2018-02-26

Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia

Phase 3 Unknown

450 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03262948 2017-11-13

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

Phase 3 Unknown

388 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02455843 2017-09-19

Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC

Phase 3 Unknown

275 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01014130 2017-07-12

CHISEL

Phase 3 Unknown

101 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02896166 2017-06-14

Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer

Phase 3 Unknown

150 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03083743 2017-03-20

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Phase 3 Unknown

417 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Thoracic Neoplasms

NCT02332512 2017-02-24

ANSWER

Phase 3 Unknown

417 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Phase 3 Unknown

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02972333 2016-11-23

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Phase 3 Unknown

150 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

134 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02938546 2016-10-21

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

Phase 3 Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02360761 2016-09-20

STEPS

Phase 3 Unknown

339 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Phase 3 Unknown

330 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02879097 2016-08-25

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

Phase 3 Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01460472 2016-07-29

Immunotherapy With Racotumomab in Advanced Lung Cancer

Phase 3 Unknown

1,082 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Clinical Trials

Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

METLUNG

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

MILES-3

MILES-4

TRAILOCLORI01

A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients

Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI

A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer

A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

EVIDENCE

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

SAINT

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

LUNG ART

ACROSS1

ACROSS2

OITROLC

ADJUVANT

OMEGA

FL-ALTER

SMART

Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients

CONSIST

Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia

Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer

Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC

CHISEL

Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

ANSWER

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study

STEPS

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

Immunotherapy With Racotumomab in Advanced Lung Cancer